1. Home
  2. XELB vs CALC Comparison

XELB vs CALC Comparison

Compare XELB & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

N/A

Current Price

$0.33

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

N/A

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

N/A

Current Price

$1.21

Market Cap

7.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XELB
CALC
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
7.6M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
XELB
CALC
Price
$0.33
$1.21
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$4.00
★ $38.00
AVG Volume (30 Days)
★ 628.8K
62.6K
Earning Date
11-16-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.37
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$30.13
N/A
Revenue Next Year
$99.55
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.44
52 Week High
$2.47
$72.00

Technical Indicators

Market Signals
Indicator
XELB
CALC
Relative Strength Index (RSI) 36.51 41.27
Support Level $0.29 $1.08
Resistance Level $0.58 $1.84
Average True Range (ATR) 0.09 0.22
MACD 0.02 0.02
Stochastic Oscillator 16.79 8.81

Price Performance

Historical Comparison
XELB
CALC

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

Share on Social Networks: